Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.

@article{Hsiao2009ChangesIP,
  title={Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: a retrospective study of physician-patient pairs in Taiwan.},
  author={Fei-Yuan Hsiao and Y Tsai and W F Huang},
  journal={Clinical therapeutics},
  year={2009},
  volume={31 11},
  pages={2618-27}
}
BACKGROUND Safety concerns regarding severe cardiovascular events associated with the use of selective cyclooxygenase-2 (COX-2) inhibitors resulted in the market withdrawal of rofecoxib in September 2004. OBJECTIVE Using Taiwan's National Health Insurance 2003-;2004 claims database, this population-based retrospective cohort study assessed changes in physicians' practice of prescribing a COX-2 inhibitor after market withdrawal of rofecoxib. METHODS Patients with rheumatoid arthritis (RA) or… CONTINUE READING
7 Citations
23 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 23 references

and Drug Administration

  • US Foo
  • Public health advisory—FDA announces important…
  • 2008

Similar Papers

Loading similar papers…